Introduction {#sec1_1}
============

In a systematic review of 18 recruited cohorts, the stroke risk was reported to be 3.1 and 5.2% on days 2 and 7, respectively, after a transient ischemic attack (TIA) \[[@B1]\]. Studies on stroke risk after TIA were predominantly conducted in Western populations, data in Chinese or Asians are limited. Existing data suggest that there are differences in nonmodifiable risk factors and pathophysiological mechanisms of cerebrovascular diseases between Chinese/Asians and Caucasians \[[@B2],[@B3],[@B4],[@B5],[@B6],[@B7],[@B8],[@B9],[@B10]\]. High levels of the apolipoprotein B/AI ratio are associated with intracranial atherosclerotic stenosis \[[@B9]\], and cerebral microbleeds may increase the risk for subsequent ischemic stroke after TIA within 3 months \[[@B11]\]. A systemic review and meta-analysis of five Western versus 4 Chinese and 1 Japanese cohort found a significant association of cerebral microbleeds with recurrent ischemic stroke in Western but not in the Chinese and Japanese cohorts \[[@B10]\]. Primarily, extracranial stenosis is more common in Caucasians, while intracranial stenosis predominates in Asians \[[@B2],[@B3],[@B12],[@B13]\]. A total of 95% of the population in Hong Kong is Chinese. The objectives of this study were to explore the short-term stroke risk after a TIA and the applicability of the ABCD^2^ score \[[@B14]\] in a local Chinese population.

Methods {#sec1_2}
=======

Setting {#sec2_1}
-------

This study was conducted in 13 acute public hospitals managed by the Hong Kong Hospital Authority (HA). The HA is a statutory organization subsidized by the government managing all public hospitals in Hong Kong \[[@B15]\]. It comprises 95% of the market share of hospitalized patients, and provides universal access to primary, secondary and tertiary health care for the 6.9 million population \[[@B16]\]. In 2006, there were 1.9 million emergency department (ED) visits. The compulsory International Classification of Diseases, Ninth Revision (ICD9) e-coding was applied to all inpatients. The study was approved by the Ethics Committees of the 13 hospitals.

Study Design and Data Collection {#sec2_2}
--------------------------------

A cohort of cerebral TIA patients, with the code ICD9 435.9, admitted to 13 acute hospitals through the ED in 2006, before the publication of the ABCD^2^ score, was recruited through the centralized electronic database of the HA Clinical Data Analysis and Reporting System (fig. [1](#F1){ref-type="fig"}). The ED, inpatient and follow-up records were traced up to 90 days from the occurrence of the index TIA (i.e. the patient had the first TIA in 2006). The day of stroke was counted from the day of ED registration to the day when the stroke occurred. TIA and stroke were defined according to the WHO criteria \[[@B17]\].

Data on patient demographics, symptomatology, investigations, medications, and clinical outcome were collected and the ABCD^2^ score was calculated. Two independent reviews by at least two physician coinvestigators were conducted together to ensure data accuracy. Our neurologist coauthor (W.C.F.) ascertained the diagnosis of TIA, he would be consulted when the opinions of the coinvestigators differed. A carotid bruit was coded absent unless it was specifically noted in the record. Atrial fibrillation was considered new if present in the index TIA, but absent in the past records.

We considered that some TIA patients could have a stroke during hospitalization and that these patients might not be recorded if coded stroke instead of TIA upon discharge. Therefore, we compared the stroke risk of a separate TIA cohort, with compulsory ICD9 e-coding, diagnosed by and recruited in six ED with this cohort. The TIA cohort diagnosed by the ED would give an estimate on possible missed recording of early stroke occurrence being coded stroke instead of TIA in the hospital.

Data Analysis {#sec2_3}
-------------

The association of demographic characteristics, stroke risk factors, and ABCD^2^ score with the risk of subsequent stroke was evaluated using the χ^2^ test or Fisher Exact test wherever appropriate. Cox regression analysis was used to identify factors that increased the risk of subsequent stroke after a TIA. Variables set at p \< 0.1 in the initial univariate analyses and associated with stroke risk were included in the Cox regression model. The ABCD^2^ score was forced into the model because it was our study objective. In the final multivariate analyses, statistical significance was achieved if p \< 0.05. The log rank test was used to assess the difference in stroke-free survival between groups stratified by the ABCD^2^ score. The test for trend was used to determine the linear relationship between stroke risk and value of the ABCD^2^ score. Sensitivity and specificity of stroke risk were determined at each cutoff of the ABCD^2^ score. In addition, the area under the receiver operating characteristic (ROC) curves was calculated. All analyses were conducted using the Statistical Package for Social Sciences, version 15.0 (SPSS Inc., Chicago, Ill., USA).

Results {#sec1_3}
=======

A total of 1,000 patients were analyzed and 4 non-Chinese and 213 patients not meeting the TIA definition by the WHO \[[@B17]\] were excluded (fig. [1](#F1){ref-type="fig"}). Forty-five percent of these patients was treated in the acute stroke units \[[@B18]\], the rest was treated in medical wards and received inpatient neurology consultation. Symptom resolution upon or before arrival at the ED occurred in 483 patients (48.3%), 517 had symptom resolution in the hospital within 24 h from onset. Five patients arrived at the ED \>72 h after symptom onset. In 91.1% of the 483 patients who arrived within 24 h of symptom onset, symptoms resolved before attending the ED.

Table [1](#T1){ref-type="table"} summarizes the baseline characteristics. The mean age was 67.8 years and there was a slight male predominance. The mean length of hospital stay was 3.1 days (median 2.5, standard deviation 4.3) and the most common comorbidity was hypertension. The top three presenting symptoms were focal weakness (64.9%), speech impairment (35.0%), and sensory disturbance (28.3%). In univariate analysis, history of diabetes, prior stroke and presence of carotid bruit or stenosis were significantly associated with developing stroke by 90 days (table [1](#T1){ref-type="table"}). The presence of old or new infarcts on CT or MRI was associated with increased stroke risk at 90 days, but not at 7 and 30 days (table [2](#T2){ref-type="table"}). In 446 patients, carotid Doppler was performed until 4 months after discharge (table [3](#T3){ref-type="table"}): 58.7% of them had normal findings and 6.1% had stenosis ≥70%, and were found to have an increased 30- and 90-day stroke risk (table [4](#T4){ref-type="table"}). Diabetes, previous stroke, and abnormal Doppler were selected for the final multivariate model. However, including the ABCD^2^ score, none of them were associated with stroke risk.

Antiplatelet agents were prescribed in 89%, warfarin in 6.9%, statin in 28.6%, antihypertensives in 39.3%, and antidiabetics in 11.9% of patients after hospitalization. Before the index TIA, 27.6% of the cohort was already taking antiplatelets, 3.7% was on oral anticoagulants, 11.3% on statin, 27.1% on antihypertensives, and 9.7% on antidiabetics. Dual therapy with aspirin and clopidogrel was not yet practiced. One patient had carotid endarterectomy on day 38, 1 patient had right carotid stenosis, and \>70% of patients had angioplasty and stenting on day 30.

The stroke risk on days 2, 7, 30, and 90 was 0.2, 1.4, 2.9, and 4.4%, respectively. There were 43 ischemic strokes and one hemorrhagic stroke in 90 days. Forty-six patients had a recurrent TIA. Eight patients died within 90 days after the index TIA (4 deaths were stroke-related, 1 was due to bleeding from a pontine hemangioma, 1 to pancreatic cancer, 1 to chest infection, 1 to chronic renal failure, and 1 to an endarterectomy complication).

A total of 47.7% of our patients were classified as ABCD^2^ moderate risk score 4-5, most patients (26.8%) as score 5, and 32.7% within the high-risk scores 6-7. The log rank tests for stroke-free survival on days 7, 30, and 90 were insignificant. The test for linear trend across the ABCD^2^ score was only significant for stroke risk on day 30. The area under the curve (AUC) of the ROC curve for stroke on days 7, 30, and 90 was 0.607, 0.607, and 0.574, respectively (table [5](#T5){ref-type="table"}). The significance test and ROC curve were not performed for day 2 stroke risk with a small number of stroke cases.

In the ED comparison cohort, there were 366 ED-coded TIA diagnosed by emergency physicians. After excluding 15 miscodings, losses to follow-up, non-Chinese patients, and 62 TIA mimics, the stroke risks of the 289 ED-diagnosed TIA were 0.35, 2.4, 5.2, and 6.2%, respectively (table [6](#T6){ref-type="table"}).

Discussion {#sec1_4}
==========

Misdiagnosis of TIA by non-neurologists is common \[[@B19],[@B20]\]. We aimed at analyzing samples with an accurate diagnosis. With 45% of subjects admitted to the acute stroke unit, 517 subjects with symptom resolution at the hospital, and 66 TIA mimics excluded, the accuracy of TIA diagnosis in our cohort was high.

Three possibilities that could account for the low stroke risk were examined: (1) nonurgent treatments were provided, (2) strokes which happened after admission could be missed, or (3) a difference between Chinese and Caucasians was made.

Before the ABCD^2^ score was derived in November 2007 by Johnston, treatment and assessments were not considered urgent in our Hong Kong public hospitals, antiplatelet was not urgently prescribed and taken, a target LDL cholesterol of 2.6 was not set, and blood pressure lowering was not optimal. Dual therapy with aspirin and clopidogrel was not yet administered. Similar to the cohort patients under treatment (n = 1,707; aspirin 68%, ticlopidine 12%, and anticoagulation 14%) \[[@B14],[@B21]\] in Johnston\'s ABCD^2^ score derivation study conducted in 16 ED in Northern California (1997-1998), 89% of our patients were put on antiplatelets and 6.9% on anticoagulant on discharge (table [7](#T7){ref-type="table"}); however, the treatments were not immediately started both in Johnston\'s derivation cohort and in our cohort. First, unlike the SOS-TIA round-the-clock clinic \[[@B22]\] with senior vascular neurologists on duty call, providing assessments with neurological, arterial, and cardiac imaging within 4 h after admission, a target blood pressure of \<130/85 mm Hg, LDL cholesterol \<2.56 mmol/l, and second, unlike phase 2 of the EXPRESS \[[@B23]\] study which provided immediate referral, assessment and intensive treatments, with 300 mg of aspirin taken in the clinic, 84% of patients put on statin, and a median time of seeking medical attention to first prescription of 1 day \[[@B23]\], the assessments and treatments initiated in our ED were not as intensive, immediate and urgent in pace. In 2006, though most of our CTs of the brain were taken within 24 h after admission, most of the MRIs of the brain and vascular assessments took place many weeks after discharge from hospital. The benefit of aspirin in lowering stroke risk in our Chinese cohort was confirmed in our study, and was previously shown in the Chinese Acute Stroke Trial (CAST) \[[@B24]\] and the combined analysis of CAST and International Stroke Trial (IST) \[[@B25]\] that shows a reduction of 0.7% in recurrent ischemic stroke in the group receiving aspirin compared with the placebo group at 4 weeks.

Surgical intervention has been shown to have no influence on the finding of low risk in our study \[[@B26]\]. The only patient with endarterectomy at day 38 died shortly after the operation, 1 patient with carotid angioplasty and stenting at day 30 did not suffer a stroke within 90 days.

We addressed the possibility that some TIA patients could have suffered a stroke shortly after admission, and could have been coded stroke, and therefore, failed to be recorded. After separately probing the 289 TIA cases (TIA mimics excluded) with compulsory ICD9 e-coding diagnosed in the 6 ED, we did not find the ED-diagnosed TIA cases to have a higher 2-day stroke rate shortly after admission (table [6](#T6){ref-type="table"}). The effect of missed recording was insignificant.

We compared Johnston\'s cohorts with ours (table [7](#T7){ref-type="table"}). Many similarities were observed, for example, there was a similar percentage of patients receiving antiplatelets and anticoagulant in our cohort and Johnston\'s ABCD^2^ derivation and validation groups. The major difference between the two is the patients\' ethnicity. Therefore, we conclude that our finding of a lower stroke risk cannot be attributed to the nonurgent treatment alone, but to the inherent pathophysiological mechanisms including the difference in epidemiology in extra- and intracranial stenosis and the nonmodifiable factors that differ between Chinese and Caucasians \[[@B2],[@B3],[@B4],[@B5],[@B6],[@B7],[@B8],[@B9],[@B10]\].

In the Chinese population, intracranial stenosis and small vessel disease occur more often, and the distal branches of the intracranial cerebral vessels are commonly involved \[[@B2],[@B3],[@B4],[@B5],[@B12]\]. Most of the severe atherosclerotic narrowing is located in the very distal branches in the leptomeningeal surfaces \[[@B5]\]. Previous studies have shown that the risk of stroke was higher in patients with large artery atherosclerosis, mostly carotid stenosis \[[@B27],[@B28]\]. Our CT and MRI findings are consistent with a higher prevalence of intracranial small vessel disease in Chinese (table [3](#T3){ref-type="table"}). Furthermore, our low rate (4.2%) of carotid bruit and the low rate (6.1%) of carotid stenosis of ≥70% in the carotid Doppler echocardiogram and previous studies confirm that extracranial large artery disease is less common in this community \[[@B2],[@B3],[@B5],[@B12],[@B13]\]. A meta-analysis by Lovett et al. \[[@B28]\] found that recurrent stroke risk varied between subtypes of ischemic stroke, the risks being 4% at 7 days and 12.6% at 30 days in patients with large artery atherosclerosis compared with 0 and 2%, respectively, in patients with lacunar stroke. Compared with other subtypes, patients with stroke due to large artery atherosclerosis had the highest odds of recurrence at 7, 30 days, and 3 months (OR = 2.9-3.3) for stroke recurrence at 30 days for small vessel stroke (OR = 0.2) \[[@B28]\]. A lower short-term stroke risk in our Chinese cohort with more intracranial small vessel disease and lacunar infarcts is consistent with the findings in Lovett et al.\'s \[[@B28]\] meta-analysis.

Furthermore, the lower stroke risk in our study might be attributed to the good collateral compensation via leptomeningeal anastomosis in Chinese patients, in whom intracranial stenosis predominates. A study performed at the university hospital of the Chinese University of Hong Kong found that 61 of the 69 patients (88.4%) suffering from TIA or minor stroke with intracranial stenosis had a good collateral circulation score. They observed that good collateral compensations are important in patients with symptomatic intracranial stenosis and compromised antegrade flow and are associated with favorable outcome and less recurrence risk \[[@B29]\].

ABCD^*2*^ Score Predictability {#sec2_4}
------------------------------

Except for the p for trend across ABCD^2^ score levels at 30 days which showed a higher stroke risk with higher scores, the ABCD^2^ score was found to have a low predictive value (table [5](#T5){ref-type="table"}). One possible reason is the overall small number of stroke cases in the sample, making this study underpowered in evaluating the usefulness of the predictive tool. Difference in patients\' ethnicity, cerebrovascular pathophysiology and the prevalence of risk factors between our sample and the ABCD^2^ derivation cohort \[[@B14]\] would, however, account for the difference.

In fact, the predictive value of the ABCD^2^ score shows marked variations in different clinical settings, such as ED, clinics, specialist units or population base \[[@B30]\]. Multiple validations of the ABCD^2^ scoring have reported inconsistent results, from excellent predictive value \[[@B31]\] to little better than chance \[[@B32]\]. A prospective study in Canada conducted in 2011 found both low stroke risk and ABCD^2^ low predictive value in stroke after TIA \[[@B33]\]. There are also findings showing that the ABCD^2^ score is unable to give good predictive values in TIA confirmed by a neurologist, adjudication committee or specialist \[[@B33],[@B34],[@B35]\], but paradoxically it gives good prediction in subjects diagnosed by a nonspecialist \[[@B14],[@B34]\].

The arbitrary 24-hour time- or tissue-based definition of TIA is controversial \[[@B36]\], and some studies include minor strokes \[[@B23],[@B27],[@B37],[@B38],[@B39]\], but with different definitions of minor strokes \[[@B40]\], this could likely be the source of the variations found \[[@B41]\].

Strengths {#sec2_5}
---------

This is a multicenter cohort. The compulsory ICD9 e-coding of inpatients guaranteed complete TIA case entry. Diagnosis was made by neurologists. Our exclusion of probable TIA or TIA mimics enhanced the accuracy of stroke risk. Like in Johnston\'s cohorts, 51.7% of our patients had witnessed symptoms which resolved in hospital -- rather than recalled symptoms -- which further ensured an accurate diagnosis. A total of 95.7% of our patients arrived within 24 h from symptom onset which reinforced the 2-day stroke risk reliability.

Limitations {#sec2_6}
-----------

This is not a population-based study. This sample represents patients treated in public ED only, though all patients calling 999 for ambulance will be transported to the nearest ED. Those who suffered a stroke a few hours after a TIA might have been coded as stroke patients \[[@B42]\]. Those with absence of speech or motor symptoms and short duration of symptoms might have delayed seeking medical attention \[[@B43]\], or might have attended private practitioners, or not sought treatment at all. Only six ED with compulsory e-coding were recruited for stroke risk comparison.

Clinical Implications {#sec2_7}
---------------------

It is no longer ethical to conduct a prospective study by withholding early treatments for observing strokes happening after TIA. However, noting the differences in pathophysiological mechanisms of cerebrovascular diseases between Chinese/Asian and Caucasians \[[@B2],[@B3],[@B4],[@B5],[@B6],[@B7],[@B8],[@B9],[@B10]\], our results serve to remind us of Giles and Rothwell\'s \[[@B1]\] statement that caution is required in extrapolating Caucasian results to nonwhite populations, as the short-term prognosis after TIA might differ.

If the short-term stroke risk after a TIA is low in the Chinese ethnicity most of our patients do not have to be immediately hospitalized when attending an ED. Joint management with the neurologist with an agreed clinical guideline on fast workups in ED, and fast-track follow-up in an outpatient TIA clinic by neurologists would be a safe and cost effective option \[[@B22],[@B23]\]. Hospitalization with rapid investigations requires many resources, especially in localities with limited access to advanced imaging which cannot afford to hospitalize most TIA patients \[[@B33]\]. Our society is facing the challenge of an aging population, 17% of the population will be aged \>65 years by 2020 \[[@B15]\]. To avoid undertreating the vulnerable and salvageable ones in this community, we suggest prompt antiplatelet administration after urgent CT of the brain, and early combined carotid/transcranial ultrasound to identify high-risk individuals with high-grade stenosis in ED in planning urgent and aggressive prevention therapies \[[@B32],[@B35]\], for those with CT or MRI positive of infarct, or carotid Doppler showing stenosis ≥70%.

Conclusion {#sec1_5}
==========

Hong Kong Chinese TIA patients have a lower short-term stroke risk. The nonurgent treatment started cannot solely explain the favorable outcome, the lower risk can be due to the different pathophysiological mechanisms of stroke between Caucasians and Chinese. The predictive value of the ABCD^2^ score in stroke risk after a TIA is low in this locality.

Appendix {#sec1_6}
========

Hong Kong TIA (HKTIA) Project Investigators {#sec2_8}
-------------------------------------------

*Participating Centers (Site Lead Coordinator and Coinvestigators)*. Alice Ho Miu-Ling Nethersole Hospital, North District Hospital (L.H.S. Chiu); Caritas Medical Centre (Kei-Fung Lam, MRCS Edin); Kwong Wah Hospital (Fu-Ping Sin, FHKCEM): Pamela Youde Nethersole Eastern Hospital (T.T. Au); Princess Margret Hospital (L.H.S. Chiu, C.T. Tsui); Prince of Wales Hospital (Chi-Wang Lam, FHKCEM); Queen Elizabeth Hospital (W.H. Yau); Queen Mary Hospital (L.P. Leung); Ruttonjee and Tang Shiu-Kin Hospital (K.A. Wan); Tseung Kwan O Hospital (Tak Shun Poon, FHKCEM); Tuen Mun Hospital (S.H.J. Chung); Yan Chai Hospital (P. Pang).
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![Flow chart showing the patients\' recruitment. In 2006, all 14 acute public hospitals were managed by the HA according to the ICD9.](cee-0004-0040-g01){#F1}

###### 

Characteristics of 1,000 patients associated with a 90-day stroke risk

  Variable                                                                    n              \%     90-day stroke risk with characteristics, %   P value   
  --------------------------------------------------------------------------- -------------- ------ -------------------------------------------- --------- ----------------------------------------
  *Characteristics*                                                                                                                                        
  Age ≥60                                                                     721            72.1   4.4                                          4.3       0.924[^b^](#T1F2){ref-type="table-fn"}
   Mean ± SD                                                                  67.8 ± 12.9                                                                  
   Range                                                                      22, 96                                                                       
  Female                                                                      432            43.2   4.4                                          4.4       
   Mean systolic blood pressure ± SD, mm Hg                                   159.5 ± 30.0                                                                 
   Systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg   741            74.1                                                          
  Medical history                                                                                                                                          
   Diabetes                                                                   273            27.3   6.6                                          3.6       0.038[^b^](#T1F2){ref-type="table-fn"}
   Hypertension                                                               583            58.3   4.3                                          4.6       0.838[^b^](#T1F2){ref-type="table-fn"}
   Hyperlipidemia                                                             176            17.6   6.3                                          4.0       0.187[^b^](#T1F2){ref-type="table-fn"}
   Ischemic heart disease                                                     106            10.6   4.7                                          4.4       0.803[^a^](#T1F1){ref-type="table-fn"}
   Carotid bruit and/or stenosis                                              30             3.0    13.3                                         4.1       0.039[^a^](#T1F1){ref-type="table-fn"}
   Previous TIA                                                               89             8.9    5.6                                          4.3       0.584[^a^](#T1F1){ref-type="table-fn"}
   Previous stroke                                                            200            20.0   7.0                                          3.8       0.045[^b^](#T1F2){ref-type="table-fn"}
   Ever smoker                                                                379            37.9   4.5                                          4.3       0.918[^b^](#T1F2){ref-type="table-fn"}
  Symptoms analysis                                                                                                                                        
   Symptoms on ED arrival                                                     517            51.7   4.3                                          4.6       0.817[^b^](#T1F2){ref-type="table-fn"}
   Focal weakness                                                             649            64.9   5.1                                          3.1       0.151[^b^](#T1F2){ref-type="table-fn"}
   Sensory disturbance                                                        283            28.3   3.2                                          4.9       0.237[^b^](#T1F2){ref-type="table-fn"}
   Speech impairment                                                          350            35.0   4.9                                          4.2       0.605[^b^](#T1F2){ref-type="table-fn"}
   Visual disturbance                                                         83             8.3    2.4                                          4.6       0.573[^a^](#T1F1){ref-type="table-fn"}
   Dizziness                                                                  191            19.1   4.7                                          4.3       0.815[^b^](#T1F2){ref-type="table-fn"}
   Vertigo                                                                    21             2.1    4.8                                          4.4       0.615[^a^](#T1F1){ref-type="table-fn"}
   Loss of consciousness                                                      41             4.1    0                                            4.6       0.253[^a^](#T1F1){ref-type="table-fn"}
   Mouth deviation/facial asymmetry                                           84             8.4    4.8                                          4.4       0.782[^a^](#T1F1){ref-type="table-fn"}
   History of atrial fibrillation                                             122            12.2   4.1                                          4.4       0.862[^b^](#T1F2){ref-type="table-fn"}
   New atrial fibrillation                                                    22             2.2    0                                            4.5       0.619[^a^](#T1F1){ref-type="table-fn"}
   Carotid bruit present on examination                                       41             4.1    12.2                                         4.1       0.030[^a^](#T1F1){ref-type="table-fn"}

Fisher\'s exact test

χ^2^ test.

###### 

Infarct and stroke risk

                                                                  Stroke   No stroke
  --------------------------------------------------------------- -------- -----------
  CT and MRI, and occurrence of stroke (at 90 days)^1^                     
   Old or new infarct either on CT or MRI                         22       330
   No infarct detected on both CT and MRI                         21       617
                                                                           
  Total                                                           43       947
                                                                           
  CT and MRI, and occurrence of stroke (at 90 days)^2^                     
   Old infarct either on CT or MRI                                13       141
   No infarct detected on both CT and MRI                         21       617
                                                                           
  Total                                                           34       758
                                                                           
   ^1^ Fisher\'s exact test, p = 0.034, OR = 1.96 (1.06--3.62).            
   ^2^ χ^2^ test, p = 0.005, OR = 2.71 (1.33--5.54).                       

###### 

Investigation results

  Variable                                             n (%)
  ---------------------------------------------------- -------------
  Echocardiogram                                       113
   No thrombus                                         112
   Vegetation                                          1
  CT of the brain/within 24 h after arrival            994/974
   Normal                                              546
   New/old lacunar infarct                             181/144
   Hypodensity and decreased attenuation               114
   Small vessel disease                                58
   Periventricular white matter disease                47
   Cerebral atrophy, encephalomalacia, aging changes   10
   Chronic subdural hematoma/effusion                  1/1
   Other findings                                      14
  MRI of the brain                                     124
   New/old lacunar infarct                             22/11
   Small vessel disease                                14
  MRA                                                  77
  Transcranial Doppler                                 44
  Cerebral angiography                                 3
                                                       
  Carotid Doppler                                      446
   Normal                                              262 (58.7%)
   Stenosis                                            
   \<50%                                               128 (28.7%)
   50--69%                                             29 (6.5%)
   ≥70%                                                27 (6.1%)

In patients with MRA, transcranial Doppler and cerebral angiography were performed. Fifty patients were found to have mild-to-severe, single or multiple sites of intracranial stenosis.

###### 

Stroke risk of carotid stenosis ≥70% compared with normal Doppler

                           Stroke   No stroke   OR (95% CI)          p value[^a^](#T4F1){ref-type="table-fn"}
  ------------------------ -------- ----------- -------------------- ------------------------------------------
  Within 7 days                                                      
   Doppler stenosis ≥70%   2        25          6.91 (1.10--43.30)   0.071
   Normal Doppler          3        259                              
  Within 30 days                                                     
   Doppler stenosis ≥70%   4        23          6.34 (1.73--23.26)   0.013
   Normal Doppler          7        255                              
  Within 90 days                                                     
   Doppler stenosis ≥70%   4        23          3.62 (1.08--12.14)   0.050
   Normal Doppler          12       250                              

Fisher\'s exact test.

###### 

Stroke risk at 2, 7, 30, and 90 days stratified according to the ABCD^2^ score

  ABCD^2^ score   Patients, n   2 days   7 days                                                                                                                                                                  30 days                                                                                                                                                                  90 days                                                                                                                                                                                         
  --------------- ------------- -------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------- ---- -----------------
  0               2             0        0                                                                                                                                                                       0                                                                                                                                                                        0                                                                                                                                                                        0                 0    0
  1               21            0        0                                                                                                                                                                       0                                                                                                                                                                        0                                                                                                                                                                        0                 0    0
  2               52            0        1                                                                                                                                                                       1.9 (0--5.5)                                                                                                                                                             1                                                                                                                                                                        1.9 (0--5.7)      1    1.9 (0--5.7)
  3               121           0        2                                                                                                                                                                       1.6 (0--3.9)                                                                                                                                                             2                                                                                                                                                                        1.7 (0--3.9)      5    4.1 (0.6--7.7)
  4               209           0        1                                                                                                                                                                       0.5 (0--1.4)                                                                                                                                                             6                                                                                                                                                                        2.9 (0.6--5.1)    9    4.3 (1.6--7.1)
  5               268           1        3                                                                                                                                                                       1.1 (0--2.4)                                                                                                                                                             6                                                                                                                                                                        2.2 (0.5--4.0)    10   3.7 (1.5--6.0)
  6               249           0        3                                                                                                                                                                       1.2 (0--2.6)                                                                                                                                                             8                                                                                                                                                                        3.2 (1.0--5.4)    12   4.8 (2.2--7.5)
  7               78            1        4                                                                                                                                                                       5.1 (0.2--10.0)                                                                                                                                                          6                                                                                                                                                                        7.7 (1.8--13.6)   7    9.0 (2.6--15.3)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  Total           1,000         2        14                                                                                                                                                                      1.4 (0.7--2.1)                                                                                                                                                           29                                                                                                                                                                       2.9 (1.9--3.9)    44   4.4 (3.1--5.6)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                         AUC = 0.607 (95% CI: 0.433--0.780); log rank test = 10.1, d.f. = 7, p = 0.186; p for trend across the ABCD^2^ score levels = 0.172; OR = 1.33 (0.88--2.02), p = 0.179   AUC = 0.607 (95% CI: 0.498--0.715); log rank test = 8.719, d.f. = 7, p = 0.273; p for trend across the ABCD^2^ score levels = 0.038; OR = 1.36 (1.01--1.83), p = 0.040   AUC = 0.574 (95% CI: 0.486--0.662); log rank test = 6.394, d.f. = 7, p = 0.495; p for trend across the ABCD^2^ score levels = 0.062; OR = 1.24 (0.99--1.57), p = 0.066                          

###### 

Stroke risk of the TIA comparison cohort diagnosed by the ED

                        Patients, n   2 days   7 days   30 days           90 days                         
  --------------------- ------------- -------- -------- ----------------- --------- ---------------- ---- ----------------
  TIA mimics included   351           1        7        1.99 (0.5--3.5)   15        4.3 (2.2--6.4)   18   5.1 (2.8--7.4)
  TIA mimics excluded   289           1        7        2.4 (0.6--4.2)    15        5.2 (2.6--7.8)   18   6.2 (3.4--9.0)

###### 

Comparison of Johnston\'s ABCD^2^ derivation and validation groups with our study

                                              Johnston\'s ABCD^2^ derivation and validation group \[[@B14]\]               Hong Kong TIA study
  ------------------------------------------- ---------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------
  Study design                                Retrospective but prospectively enrolled data from a computerized database   Retrospective but prospectively compulsory e-coded data from a computerized database and hard copies
                                                                                                                           
  Country                                     Oxford (UK) and California (USA)                                             Hong Kong
                                                                                                                           
  Year                                        1998--2005 in the validation group                                           2006
                                                                                                                           
  Setting                                     ED cohort: multiple ED Clinic cohort                                         Multiple ED
                                                                                                                           
  TIA diagnosed by                            ED cohort: ED physicians Clinic cohort: neurologists                         Neurologists or internists
                                                                                                                           
  Age                                         66--80% \>60 years                                                           72.1% \>60 years
                                                                                                                           
  Ethnicity                                   White 70--99%                                                                Chinese 100%
                                                                                                                           
  Symptom onset on ED arrival or evaluation   0--0 day and 0--3 days                                                       0--3 days (96%, 0--1 day)
                                                                                                                           
  Symptomatic on arrival                      50% of the California derivation group                                       51.7%
                                                                                                                           
  How the 'day of stroke' was counted         From day of evaluation in the clinic or ED to day of stroke                  From day of ED registration to day of stroke
                                                                                                                           
  Prior stroke                                0--20%                                                                       19.9%
                                                                                                                           
  On antiplatelet on discharge                81--99% in the validation group                                              89%
                                                                                                                           
  On anticoagulation on discharge             4--14%                                                                       6.9%
